Management of bleeding problems with hormone replacement therapy

Journal of Family Planning and Reproductive Health Care

Volumn 28, Issue 4, 2002, Pages 182-184

  Hillard, Tim ^a  

^a POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GESTAGEN; TIBOLONE;

AMENORRHEA; ENDOMETRIUM BIOPSY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYSTEROSCOPY; MENSTRUAL CYCLE; OVARY CYCLE; PATIENT COMPLIANCE; PATIENT COUNSELING; PELVIS; PREGNANCY; SHORT SURVEY; TRANSVAGINAL ECHOGRAPHY; VAGINA BLEEDING; WITHDRAWAL BLEEDING;

DRUG ADMINISTRATION SCHEDULE; ENDOMETRIUM; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; POSTMENOPAUSE; PROGESTERONE CONGENERS; UTERINE HEMORRHAGE;

EID: 0036816274     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1783/147118902101196801     Document Type: Short Survey

References (33)

1. Sturdee DW, Wade-Evans T, Patterson MEL, et al. Relationship between bleeding patterns, endometrial histology and oestrogen treatment in menopausal women. BMJ 1978; 1: 1575-1577.
2. Whitehead MI, Townsend PT, Pryse-Davies J, et al. Effects of oestrogen and progestins on the biochemistry and morphology of the postmenopausal endometrium. N Engl J Med 1981; 305: 1599-1605.
3. The Writing Group for the PEPI Trial. Effects of hormone replacement therapy on endometrial histology in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions Trial. JAMA 1996; 275: 370-375.
4. Persson I, Adami HO, Bergvist L, et al. Risk of endometrial cancer after treatment with oestrogen alone or in conjunction with progestogens: Results of a prospective study. BMJ 1989; 298: 147-151.
5. DeLeo V, la Marca A, Morgante G, et al. Comparison of two HRT regimens with bimonthly and monthly progestin administration in postmenopause. Maturitas 1999; 31: 171-177.
6. Ettinger B, Pressman A, Van Gessel A. Low-dosage esterified estrogens opposed by progestin at 6-month intervals. Obstet Gynecol 2001; 98: 205-211.
7. Rozenberg S, Caubel P, Lim PC. Constant estrogen, intermittent progestogen vs continuous combined hormone replacement therapy: Tolerability and effect on vasomotor symptoms. Int J Gynecol Obstet 2001; 72: 235-243.
8. Ettinger B, Li DK, Klein R. Unexpected vaginal bleeding and associated gynecological care in postmenopausal women using hormone replacement therapy: Comparison of cyclic versus continuous combined schedules. Fertil Steril 1998; 69: 865-869.
9. Al-Azzawi F, Wahab M, Thompson J, et al. Acceptability and patterns of endometrial bleeding in estradiol-based HRT regimens: A comparative study of cyclical sequential combinations oftrimegestone or norethisterone acetate. Climacteric 2001; 4: 343-354.
10. Koninckx PR, Lauweryns JM, Cornille FJ. Endometrial effects during hormone replacement therapy with a sequential, oestradiol valerate/cyproterone acetate preparation. Maturitas 1993; 16: 97-110.
11. Blanc B, Cravello L, Micheletti MC, et al. Continuous hormone replacement therapy for menopause combining nomegestrol acetate and gel, patch or oral estrogen: a comparison of amenorrhea rates. Clin Ther 1998; 20: 901-912.
12. Curran MP, Wagstaff AJ. Estradiol and norgestimate. A review of their combined use as hormone replacement therapy in postmenopausal women. Drugs Aging 2001; 18: 863-885.
13. Ross D, Cooper AJ, Pryse-Davies J, et al. Randomised double-blind dose ranging study of the endometrial effects of a vaginal progesterone gel in estrogen treated postmenopausal women. Am J Obstet Gynecol 1997; 177: 937-941.
14. Drugs and Therapeutics Bulletin. "Natural" progesterone creams for postmenopausal women. Drug Ther Bull 2001; 39: 10-11.
15. Suvanto-Luukkonen E, Kauppila A. The levonorgestrel intrauterine system in menopausal hormone replacement therapy: 5 Year experience. Fertil Steril 1999; 72: 161-163.
16. Whitehead MI, Hillard TC, Crook D. The role and use of progestogens. Obstet Gynecol 1990; 75: 559-576.
17. Cerin A, Heldaas K, Moeller B. Adverse endometrial effects of long-cycle estrogen and progestogen replacement therapy. N Engl J Med 1996; 334: 668-669.
18. Archer DF, Dorin MH, Heine W, et al. Uterine bleeding in postmenopausal women on continuous therapy with estradiol and norethindrone acetate. Obstet Gynecol 1999; 94: 323-329.
19. Stadberg E, Mattsson L-A, Uvebrant M. 17 β-Estradiol and norethisterone acetate in low doses as continuous combined hormone replacement therapy. Maturitas 1996; 23: 31-39.
20. Hammar M, Christau S, Nathorst-Boos J, et al. A double blind randomised study comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptom. Br J Obstet Gynaecol 1998; 105: 904-911.
21. Archer DF, Pickar JH. The assessment of bleeding patterns in postmenopausal women during continuous combined hormone replacement therapy: A review of methodology and recommendations for reporting of the data. Climacteric 2002; 5: 45-59.
22. Hillard TC, Lumsden MA, Rees M, et al. Bleeding on sequential HRT and endometrial thickness predict success of transition from sequential hormone replacement therapy to continuous combined transdermal hormone replacement therapy. J Br Menopause Soc 2001; 7(Suppl. 3): 18-19.
23. Nagele F, O'Connor H, Basket TF, et al. Hysteroscopy in women with abnormal uterine bleeding on hormone replacement therapy: A comparison with postmenopausal bleeding. Fertil Steril 1996; 65: 1145-1150.
24. Sturdee DW, Ulrich LG, Barlow DH, et al. The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy. Br J Obstet Gynecol 2001; 107: 1392-1400.
25. Archer DF, Pickar JH, Bottiglioni F. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxy-progesterone acetate. Obstet Gynecol 1994; 83: 686-692.
26. Beresford SA, Weiss NS, Voigt LF, et al. Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestogen therapy in postmenopausal women. Lancet 1997; 349: 458-461.
27. Weiderpass E, Adami HO, Baron JA, et al. Risk of endometrial cancer following estrogen replacement with and without progestins. J Natl Cancer Inst 1999; 91: 1131-1137.
28. Spencer CP, Cooper AJ, Whitehead MI. Management of abnormal bleeding in women receiving hormone replacement therapy. BMJ 1997; 315: 37-42.
29. Hillard TC. Period free HRT. In: Sturdee D, Olah K, Keane D (eds), Yearbook of Obstetrics & Gynaecology. London: RCOG Press, 2001; 98-118.
30. Ginsburg J, Prelevic GM. Cause of vaginal bleeding in postmenopausal women taking Tibolone. Maturitas 1996; 24: 107-110.
31. Romer T. Treatment of recurrent bleeding disorders during hormone replacement therapy (HRT) by transcervical endometrial ablation. Gynecol Obstet Invest 1999; 47: 255-257.
32. Spencer CP, Whitehead MI. Endometrial assessment revisited. Br J Obstet Gynaecol 1999; 106: 623-632.
33. Melson L, Hillard TC. The management of abnormal bleeding on HRT - a proposed protocol and early audit of results. J Br Menopause Soc 2002; 4(Suppl. 2): in press.